Bioprocessing Facilities 2011 Conference to be held Aug. 8-9 in San Diego

The conference will detail management experience, lessons learned, findings, and insights on cGMP bioprocessing facilities including new plans for reduced capital and operating costs; successful models for people and materials flow; implementation strategies for modular and disposable technologies; capacity planning approaches for mixed-use, multiproduct facilities; plans that maximize flexibility and speed to market; advances in MEP and processing equipment and more.

Speakers will include representatives from Fraunhofer USA, on their first-of-its-kind cGMP facility for plant-based protein production that does not require large-scale culturing or fermentation processes; Statens Serum Institute of Copenhagen, Denmark, an international research, production and service enterprise involved in vaccine and biologics development and diagnostic services; and Texas A&M's 155,000-sf National Center for Therapeutics Manufacturing (NCTM), which has the capacity for developing and producing multiple biological products using multiple production technologies.

For more information about Bioprocessing Facilities 2011 click here.